Skip to main content
logo
NRx Pharmaceuticals, Inc. (NRXP)
NASDAQ: NRXP · Real-Time Price · USD
3.750
-0.360 (-8.76%)
At close: Jul 24, 2026, 4:00 PM EDT
3.760
+0.010 (0.27%)
After-hours: Jul 24, 2026, 7:50 PM EDT

NRx Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
-1.23----
Revenue Growth
------
Gross Profit
-0.72----
Operating Income
-17.12-16.22-18.5-27.84-44.34-115.8
Net Income
-24.54-28.62-25.13-30.16-39.75-348.89
Earnings Per Share
-1.09-1.34-2.36-3.98-6.00-74.40
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
6.717.81.444.620.0527.61
Total Debt
0.930.636.269.1610.530.52
Net Cash (Debt)
5.787.17-4.81-4.579.5327.09
Net Cash Growth
-----64.82%-
Net Cash Per Share
0.230.33-0.45-0.601.455.77

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-14.93-14.11-10.64-21.66-39.76-37.7
Capital Expenditures
----0-0.01-0.01
Free Cash Flow
-14.93-14.11-10.64-21.66-39.77-37.71
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-58.78%----
Operating Margin
--1324.41%----
Pretax Margin
--3215.02%----
Profit Margin
--2336.49%----
FCF Margin
--1152.00%----

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-39.16----
PS Ratio
68.5470.20----